S. Apostolaki

发表

KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer

M. Tzardi, D. Mavroudis, V. Georgoulias, 2014, PloS one.

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer

S. Agelaki, V. Georgoulias, M. Perraki, 2013, British Journal of Cancer.

Assessment of the effect of surgery on the kinetics of circulating tumour cells in patients with operable breast cancer based on cytokeratin-19 mRNA detection.

E. Sanidas, V. Georgoulias, D. Mavroudis, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.

I. Vlachonikolis, D. Mavroudis, V. Georgoulias, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer

M. Spiliotaki, G. Kallergi, V. Georgoulias, 2017, Cellular Physiology and Biochemistry.

International study on inter-reader variability for circulating tumor cells in breast cancer

S. Sleijfer, T. Fehm, E. Perez, 2014, Breast Cancer Research.

Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance

G. Kallergi, D. Mavroudis, V. Georgoulias, 2008, Breast Cancer Research and Treatment.

Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance.

S. Agelaki, V. Georgoulias, M. Perraki, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer

V. Georgoulias, M. Perraki, S. Apostolaki, 2017, Cancer Chemotherapy and Pharmacology.

Trastuzumab Administration Can Effectively Target Chemotherapy-Resistant Cytokeratin-19 Messenger RNA–Positive Tumor Cells in the Peripheral Blood and Bone Marrow of Patients With Breast Cancer

D. Mavroudis, V. Georgoulias, M. Perraki, 2004, Clinical Cancer Research.

Trastuzumab versus observation in women with early breast cancer and CK-19 mRNA-positive circulating tumor cells (CTCs): A pilot randomized phase II study.

S. Agelaki, G. Kallergi, V. Georgoulias, 2010 .

Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.

C. Sotiriou, D. Mavroudis, V. Georgoulias, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study.

S. Agelaki, G. Kallergi, V. Georgoulias, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

D. Mavroudis, V. Georgoulias, M. Ignatiadis, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancer.

D. Mavroudis, V. Georgoulias, M. Perraki, 2014, Clinical breast cancer.

Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status

D. Mavroudis, V. Georgoulias, M. Perraki, 2006, Breast Cancer Research.

Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(−) breast cancer receiving salvage treatment with everolimus/exemestane

M. Spiliotaki, G. Kallergi, V. Georgoulias, 2021, Cancer Chemotherapy and Pharmacology.

Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.

D. Mavroudis, V. Georgoulias, M. Perraki, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A highly specific real‐time RT‐PCR method for the quantitative determination of CK‐19 mRNA positive cells in peripheral blood of patients with operable breast cancer

D. Mavroudis, V. Georgoulias, M. Perraki, 2006, International journal of cancer.

Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.

I. Vlachonikolis, M. Perraki, E. Lianidou, 2003, Anticancer research.

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.

I. Vlachonikolis, D. Mavroudis, V. Georgoulias, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

G. Kallergi, D. Mavroudis, V. Georgoulias, 2008, Clinical Cancer Research.

Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib

V. Georgoulias, M. Plataki, S. Apostolaki, 2018, Scientific Reports.

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer

S. Agelaki, V. Georgoulias, M. Perraki, 2009, British Journal of Cancer.

Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.

D. Mavroudis, V. Georgoulias, M. Perraki, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

International study on inter-reader variability for circulating tumor cells in breast cancer

S. Sleijfer, T. Fehm, E. Perez, 2014, Breast Cancer Research.

Imaging , Diagnosis , Prognosis Prognostic Significance of the Detection of Peripheral Blood CEACAM 5 mRNA-Positive Cells by Real-Time Polymerase Chain Reaction in Operable Colorectal Cancer

D. Mavroudis, V. Georgoulias, M. Perraki, 2010 .

Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancer

V. Georgoulias, M. Perraki, P. Economopoulou, 2022, British Journal of Cancer.

Molecular Detection and Prognostic Value of Circulating Cytokeratin-19 Messenger RNA – Positive and HER 2 Messenger RNA – Positive Cells in the Peripheral Blood of Women with Early-Stage Breast Cancer

C. Sotiriou, D. Mavroudis, V. Georgoulias, 2008 .

Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer.

C. Sotiriou, D. Mavroudis, V. Georgoulias, 2007, Clinical breast cancer.

TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC)

V. Georgoulias, J. Souglakos, S. Apostolaki, 2017, Scientific Reports.

Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer.

D. Mavroudis, V. Georgoulias, M. Perraki, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical relevance of circulating CK-19 mRNA-positive cells detected during the period of adjuvant tamoxifen treatment in patients with early breast cancer

V. Georgoulias, M. Perraki, M. Kafousi, 2007 .

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse

S. Agelaki, G. Kallergi, D. Mavroudis, 2011, Breast Cancer Research.

Docetaxel‐induced lymphopenia in patients with solid tumors

V. Georgoulias, J. Souglakos, S. Apostolaki, 2000, Cancer.

Effect of front-line chemotherapy on circulating CK-19 mRNA-positive cells in patients with metastatic breast cancer

S. Agelaki, V. Georgoulias, M. Perraki, 2014, Cancer Chemotherapy and Pharmacology.

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumor cells in patients with early breast cancer.

S. Agelaki, D. Mavroudis, V. Georgoulias, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer

S. Agelaki, V. Georgoulias, M. Perraki, 2012, British Journal of Cancer.

Effect of adjuvant treatment on the circulating CK-19 mRNA-positive tumor cells in patients with early stage breast cancer.

V. Georgoulias, M. Perraki, E. Lianidou, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib

V. Georgoulias, M. Plataki, S. Apostolaki, 2018, Scientific Reports.

Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status

D. Mavroudis, V. Georgoulias, M. Perraki, 2006, Breast Cancer Research.

Prognostic significance of the detection of peripheral blood CEACAM5 mRNA-positive cells by real-time polymerase chain reaction in operable colorectal cancer (CRC)

D. Mavroudis, V. Georgoulias, I. Koutroubakis, 2010 .